ATTR Amyloidosis
7 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| The Italian Transthyretin Amyloidosis Web-Network (NCT05444920) | Fondazione IRCCS Policlinico San Matteo di Pavia | 2022-07-13 |
| ConTTRibute: A Global Observational Study of Patients With Transthyretin (TTR)-Mediated Amyloidosis (ATTR Amyloidosis) (NCT04561518) | Alnylam Pharmaceuticals | 2020-11-23 |
| The Study of an Investigational Drug, Revusiran (ALN-TTRSC), for the Treatment of Transthyretin (TTR)-Mediated Amyloidosis in Patients Whose Disease Has Continued to Worsen Following Liver Transplant (NCT02595983) | Alnylam Pharmaceuticals | 2015-10-01 |
Track ATTR Amyloidosis automatically
Every clearance here is in the API, with alerts when new ones post.